Much of our knowledge about cartilage and bone has come from descriptive anatomy, endocrinology, and cellular studies of bone turnover. Recent approaches have led to the identification of local factors that regulate skeletal morphogenesis. Molecular and biochemical studies of bone and cartilage cells in vitro, gene inactivation in mice, and the identification of genes responsible for mouse and human skeletal abnormalities have documented the importance of specific growth and differentiation factors, extracellular matrix proteins, signaling mediators, and transcription factors in bone and cartilage development. The successful convergence of mouse and human genetics in skeletal biology is illustrated in this issue of Cell with two papers that show that mutations in collagen type Xl cause chondrodysplasia both in cho/cho mice as well as in patients with Stickler syndrome (Li et al., 1995; Vikkula et al., 1995) .
Much of our knowledge about cartilage and bone has come from descriptive anatomy, endocrinology, and cellular studies of bone turnover. Recent approaches have led to the identification of local factors that regulate skeletal morphogenesis. Molecular and biochemical studies of bone and cartilage cells in vitro, gene inactivation in mice, and the identification of genes responsible for mouse and human skeletal abnormalities have documented the importance of specific growth and differentiation factors, extracellular matrix proteins, signaling mediators, and transcription factors in bone and cartilage development. The successful convergence of mouse and human genetics in skeletal biology is illustrated in this issue of Cell with two papers that show that mutations in collagen type Xl cause chondrodysplasia both in cho/cho mice as well as in patients with Stickler syndrome (Li et al., 1995; Vikkula et al., 1995) .
In general, recent results emphasize the need to view skeletal development at various integrated levels of organization and illustrate how single gene products affect development at these different levels. Pattern information determines not only the body plan of the early skeleton but also the shape of each individual skeletal element. In addition, the sequence of events during bone growth and development must be temporally and spatially controlled to ensure correct proportions of bony elements. Positional information must also regulate the establishment of bone internal structure throughout growth, while local homeostatic mechanisms must maintain bone integrity throughout adult life. Lastly, a complex extracellular matrix must generate skeletal tissues with specific biomechanical properties.
Ultimately, the morphogenesis of the skeleton derives from the regulated differentiation, function, and interactions of its component cell types. Three major cell types contribute to the skeleton: chondrocytes, which form cartilage; osteoblasts, which deposit bone matrix; and osteoclasts, which resorb bone. Chondrocytes and osteoblasts are of mesenchymal origin, whereas osteoclasts derive from the hematopoietic system. Once embedded in bone matrix, osteoblasts mature into terminally differentiated osteocytes. The activity and differentiation of osteoblasts and osteoclasts are closely coordinated during development as bone is formed and during growth and adult life as bone undergoes continuous remodeling. More specifically, the formation of internal bone structures and bone remodeling result from coupling bone resorption by activated osteoclasts with subsequent deposition of new matrix by osteoblasts (Figure 1 ). Bone remodeling also links bone turnover to the endocrine homeostasis of calcium and phosphorus, since the mineralized bone matrix serves as the major repository for these ions in the body.
Descriptive embryology and anatomy distinguish two types of bone development: intramembranous and endochondral. Intramembranous ossification occurs when mesenchymal precursor cells differentiate directly into bone-forming osteoblasts, a process employed in generating the flat bones of the skull as well as in adding new bone to the outer surfaces of long bones. In contrast, endochondral bone formation entails the conversion of an initial cartilage template into bone and is responsible for generating most bones of the skeleton. Cartilage templates originally form during embryogenesis when mesenchymal cells condense and then differentiate into chondrocytes. These cells subsequently undergo a program of hypertrophy, calcification, and cell death. Concomitant neovascularization occurs, and osteoclasts and osteoblasts are recruited to replace the cartilage scaffold gradually with bone matrix and to excavate the bone marrow cavity. Longitudinal bone growth takes place through a similar pattern of endochondral ossification in the growth plates located at the epiphyses (ends) of long bones. In these epiphyseal plates, the calcified, hypertrophic cartilage provides a scaffold for the formation of new trabecular bone. Ultimately, all remaining cartilage is replaced by bone except at the articular surfaces of the joints (Figure 2 ).
Skeletal Patterning
Classical embryology has shown that three distinct embryonic lineages contribute to the early skeleton. The neural crest gives rise to the branchial arch derivatives of the craniofacial skeleton, the sclerotome generates most of the axial skeleton, and the lateral plate mesoderm forms the appendicular skeleton. Transplantation studies have indicated that information regarding the number and ana- During a remodeling cycle, activated multinucleated osteoclasts derived from bone marrow monocytes resorb a discrete area of mineralized bone matrix. Subsequently, capillary endothelial cells provide the microvasculature, and cuboidal osteoblasts and fibroblastic osteoprogenitor cells, which can locally proliferate and differentiate into osteoblasts, migrate into the resorption lacuna. The osteoblasts deposit new bone matrix, which is initially unmineralized and called osteoid, and in this way refill the resorption lacuna. Once embedded in osteoid, the osteoblasts mature into terminally differentiated osteocytes.
Figure 2. Long Bone Growth through Endochondral Ossification
Longitudinal bone growth occurs at the epiphyseal growth plate in which chondrecytes proliferate and mature, and the calcified matrix of the hyperytrophic cartilage provides a scaffold for new trabecular bone formation. Above the growth plate, the secondary ossification center has already replaced the epiphyseal cartilage with bone and bone marrow.
tomic "identity" of derived skeletal elements already resides in these lineages by the time of their appearance and long before overt skeletogenesis. The family of transcription factors encoded by homeobox genes play a central role in this aspect of skeletal pattern formation (reviewed by Morgan and Tabin, 1993; Krumlauf, 1994) . Specific homeobox genes are expressed in distinct patterns at the time when the embryonic lineages initially form. Furthermore, targeted inactivation or ectopic expression of these genes in the mouse results in the deletion or addition of skeletal elements or in the transformation of skeletal elements into shapes resembling other elements. For example, the hoxa-2 gene is expressed in fourth rhombomere neuroepithelium before the migration of neural crest cells and their subsequent differentiation into the skeletal elements of the second branchial arch. Its localized expression combined with the results from transplantation experiments Suggests that this gene is required for the determination of second branchial arch identity. Accordingly, inactivation of the hoxa-2 gene results in the deletion of the craniofacial elements derived from the second branchial arch and their replacement by elements resembling those derived from the first branchial arch (Gendron-Maguire et al., 1993; Rijli et al., 1993) . Thus, in the absence of the hoxa-2 gene product, the skeletogenic neural crest of the second arch defaults to a first arch identity. The same principles can be demonstrated for the axial and appendicular skeleton using the hoxd-13 homeobox gene as an example, hoxd-13 is expressed in the presomitic mesoderm of the posterior region of the embryo before sclerotome formation and appearance of the mesodermal skeletal lineages, as well as in the posterior distal region of the limb bud mesenchyme. Inactivation of the hoxd-13 gene results in a transformation of the fourth sacral vertebrae into a bone resembling the third and in an assortment of deletions and additions of distal limb skeletal elements (Doll~ et al., 1993).
The well-studied system of limb development has revealed the additional importance of inductive interactions in regulating skeletal patterning. Signals essential for limb patterning emanate from the zone of polarizing activity (ZPA), which is located in the posterior limb mesoderm underlying the apical ectodermal ridge (AER) of a developing limb bud. Transplantation of the ZPA underneath the AER on the anterior margin of another limb bud results in a mirror-image duplication of skeletal elements, a phenomenon that also occurs when retinoic acid is applied at the same anterior site. The secreted factor Sonic hedgehog (Shh) has been identified as a key inductive signal that mediates the activity of the ZPA (Riddle et al., 1993) . Shh induces fibroblast growth factor 4 (FGF-4) in the AER, which in turn also regulates Shh expression and serves as an ectodermal competence factor for Shh responsiveness in the underlying mesoderm (Laufer et al., 1994) . These inductive interactions may regulate limb skeletal patterning by establishing the expression patterns of homeobox genes in the limb bud mesenchyme. For example, Shh induces the local expression of hoxd-13, which, as mentioned above, is required for normal limb patterning. Shh also induces the local expression of bone morphogenetic protein 2 (BMP2), a transforming growth factor 13 (-rGFl~)-related factor with cartilage-inducing activity. Similar inductive interactions are likely to play an important role in skeletal patterning in other areas of the developing embryo.
Local Control of Bone Shape
The individual shapes of skeletal elements are largely determined during embryogenesis when their respective cartilage templates form from localized mesenchymal condensations. The importance of paracrine factors in regulating the process of mesenchymal condensation has been emphasized by the recent characterizations of the mouse mutations short ear (se) and brachypodism (bp) (reviewed by Kingsley, 1994) . In these mutant mice, various skeletal elements thoughout the body have altered shapes and sizes. For example, the se phenotype includes an altered shape of the sternum and the external ear cartilage, whereas the bp mutation leads to a reduction in size of appendicular long bones. These adult abnormalities can be attributed to defects in size and shape already apparent in the mesenchymal condensations of the affected skeletal elements. The se and bp mutations result from inactivation of the genes for BMP5 and GDF-5 (for growth and differentiation factor 5), two members of the TGF~ superfamily, respectively (Kingsley et al., 1992; Storm et al., 1994) . The developmental expression pattern of these two factors is consistent with their potential role in the local control of patterns of mesenchymal condensations. For example, BMP5 is expressed in condensing mesenchyme, which gives rise to external ear cartilage, whereas GDF-5 is expressed in mesenchyme surrounding limb condensations. Furthermore, the ability of BMP5 and other BMPs to induce cartilage and bone formation when injected into nonskeletal sites in vivo further supports a role for these factors in the local induction of cartilage. These factors may also be involved in fracture repair, as suggested by the increased expression of BMP4 at fracture sites (Nakase et al., 1994) and the impaired fracture healing in se mice.
The current data on the regulation of skeletogenesis suggest a two-step model for the specification of the pattern and shape of the embryonic skeleton. First, the patterned expression of homeobox genes confers information to cells of the early mesenchymal lineages that specifies the overall pattern of the skeleton and the archetypal shape and identity of the individual elements. Second, the shape of a skeletal element is further defined through the local regulation of mesenchymal condensation by secreted autocrine/paracrine factors. Phylogenetic evolution of the skeleton may result from modifications in early cellintrinsic patterning and in local control of mesenchymal condensation by these differentiation factors.
Bone Shape during Growth
Bone growth is regulated by various systemic factors. Skeletal growth ultimately ceases when the growth plate is entirely replaced with bone, a process that requires estrogen in both males and females (Federman, 1994; Smith et al., 1994) . The rate of skeletal growth until epiphyseal closure is regulated by growth hormone, which is released by the pituitary gland and acts predominantly through the local and systemic expression of insulin-like growth factor 1 (IGF-1). Mice that lack IGF-1 as a result of gene inactivation (Baker et al., 1993) and humans with reduced growth hormone levels resulting in hypopituitary dwarfism have a reduced size of the skeleton, but with only small alterations of the proportions between or within bones.
During growth, maintenance of the shapes of indK, idual bones and the relative proportions of the skeleton are likely to result from a complex process involving multiple local mediators, as suggested by the wide spectrum of clinical abnormalities related to disproportionate bone growth. In the skull, the intramembranous bones grow by peripheral addition of new bone at osteogenic fronts, which generate the suture lines. Osteoblastic differentiation within the sutures and consequent bone deposition are intimately coordinated with the growth of the skull and the timing of suture closure. Deregulated coordination results in premature suture closure, leading to various skull abnormalities collectively known as craniosynostoses. In bones that develop based on cartilage templates, endochondral ossification must be coordinated with the simultaneous growth of the epiphyses, longitudinal growth at the epiphyseal growth plate, and the radial growth of the periosteum. Achondroplasia, the most common cause of human dwarfism, results from incomplete coordination of these processes and is characterized by short, wide bones and overgrowth of the periosteum relative to the epiphyses.
Recently, cell signaling by FGFs has been implicated in coordinating proportional bone growth. At least nine members of the FGF family interact with varying specificities and affinities to four transmembrane tyrosine kinase FGF receptors, FGFR1 through FGFR4 (reviewed by Givol and Yayon, 1992) . FGF receptor signaling regulates various cellular processes, most notably the proliferation and differentiation of cells of mesenchymal and neurectodermal origin. Recently, several dominantly inherited human skeletal disorders have been correlated with mutations in FGF receptors. Mutations in the transmembrane region of FGFR3 in patients with achondroplasia suggests that impaired ligand-induced receptor dimerization and signaling may be the cause of this disease (Rousseau et al., 1994; Shiang et al., 1994) . The expression of FGFR3 in resting chondrocytes and not in the periosteum (Peters et al., 1993) may explain why achondroplasia results in abnormalities in only those bones that develop based on cartilage templates and not in the intramembranous bones of the skull. The craniosynostosis seen in Crouzon syndrome has been correlated with mutations in the extracellular domain of FGFR2, which may affect ligand binding . Finally, patients with Pfeiffer syndrome and Jackson-Weiss syndrome, which have craniosynostoses as well as limb defects, have similar mutations in FGFR1 and FGFR2, respectively (Jabs et al., 1994; Muenke et al., 1994) . It is unclear how different point mutations in FGFR2 give rise to different skeletal defects in Crouzon syndrome and Jackson-Weiss syndrome. The identification of these mutations in these inherited skeletal disorders implies a local role of FGF-mediated signaling in skeletal development and suggests transgenic approaches to the characterization of the role of these factors in skeletal development.
The restricted expression patterns of the FGFRs and their ligands and in vitro data on the effects of FGFs suggest that specific FGFs might regulate intrinsic growth rates of distinct zones of the epiphysis and that FGFmediated autocrine and paracrine interactions within and between these zones control their relative growth. An internal network of local homeostatic interactions via FGFs might then be integrated with effects of systemic factors to control overall skeletal growth and proportions.
Further evidence for such an integration of signals and communication between different zones of the epiphyseal plate comes from studies on parathyroid hormone-related protein (PTHrP). While PTHrP is expressed in various locations throughout the epiphysis, its receptor expression in growth plate cartilage is localized mainly to the transitional zone between proliferating and hypertrophic chondrocytes, suggesting that cells in this zone coordinate the rate of chondrocyte maturation. In mice with an inactivated PTHrP gene, the reduced proliferation and premature differentiation of chondrocytes in the epiphyseal plate lead to a greatly increased rate of endochondral ossification, resulting in a skeleton that is almost completely ossified by the time of birth (Amizuka et al., 1994; Karaplis et al., 1994) .
Possibly related to growth factor signaling in skeletal growth control is the recent finding that diastrophic dysplasia can be ascribed to a defect in the gene for a putative sulfate transporter (H&stbacka et al., 1994) . In this disease, the undersulfation of proteoglycans may be responsible for the mechanical defects in cartilage and bone matrix that result in a severely malformed skeleton, progressive joint disease, and dwarfism. The deformities in diastrophic dysplasia and the FGF-related diseases described above share some similarities. For example, in diastrophic dysplasia, the deformities in the short bones are similar to those seen in achondroplasia, the broad great toes are similar to Jackson-Weiss and Pfeiffer syndromes, and the broad thumbs are reminiscent of Pfeiffer syndrome. A mechanistic basis for the relationship between these two types of diseases is also suggested by the requirement of heparan sulfates for the high affinity interactions of FGF with its receptor (Yayon et al., 1991; Givol and Yayon, 1992) . Whether the defect in sulfation in diastrophic dysplasia decreases the availability of heparan sulfates and impairs FGF signaling during skeletal development remains to be tested.
The importance of transcription factors in the regulation of bone growth is illustrated by the mutation in the msx2 homeobox gene in patients with Boston-type craniosynostosis (Jabs et al., 1993) . Consistent with its involvement in suture function and closure, msx2 mRNA is localized at the sutures and various other sites during craniofacial development of the mouse. Inactivation of the closely related msxl further suggests that this class of homeobox genes plays a role in normal growth of intramembranous bones at osteogenic fronts (Satokata and Maas, 1994) . The cleft palate in these mice is due to failu re of the palatal shelves to grow toward each other and fuse and is consistent with the expression of msxl in the osteogenic fronts of the palatal shelves. Remarkably, the expression of both msxl and msx2 has been shown, at least in developing teeth, to be controlled by BMP4, a TGFI~ related factor with cartilage-and bone-inducing activity (Vainio et al., 1993) . Lastly, mutations in SOX9, which encodes a putative transciption factor related to SRY, have been shown to cause sex reversal with associated campomelic dysplasia, a congenital skeletal malformation syndrome with the prominent feature of bowed long bones (Foster et al., 1994; Wagner et al., 1994) . How this gene product is involved in bone development is unknown.
Bone Structure, Modeling, and Remodeling
The coordinated activities of osteoclasts and osteoblasts in bone resorption and deposition form the internal structure of a bone. In long bones, a tube of dense cortical bone encases the bone marrow space and is capped by the two epiphyseal growth plates. The bone marrow cavity contains a large number of bone spicules (trabeculae) arranged with increasing density toward the epiphyseal plates (Figure 2 ). The importance of bone resorption in bone modeling is illustrated by the structural defects in osteopetrosis, a disease associated with impaired osteoclastic function. While the external shapes are normal, osteopetrotic bones are characterized by a homogeneous dense trabeculation in the bone marrow space and a less compact consistency of the cortical bone. In several mouse models, the inactivation of specific genes results in impaired osteoclastic differentiation and consequent osteopetrosis. In osteopetrotic op/op mice, osteoclast differentiation is blocked at an early stage as a result of defective production of colony-stimulating factor 1 (CSF-1) (WiktorJedrzejczak et al., 1990; Yoshida et al., 1990) . The inability of bone marrow transplantation to cure this form of osteopetrosis suggests that CSF-1 is normally provided by cells external to the hematopoietic system. In contrast, several other types of osteopetrosis in mice can be rescued by bone marrow transplantation. For example, rail mi mice develop osteopetrosis as a result of a mutation in a putative transcription factor that contains a basichelix-loop-helix (bHLH) domain and a leucine zipper domain (Hodgkinson et al., 1993) . In addition, inactivation of the c-src gene results in a rescuable osteopetrosis in which the multinucleated osteoclasts are present but lack bone resorption activity (Lowe et al., 1993; Soriano et al., 1991) . Finally, inactivation of the c-fos gene also results in osteopetrosis, but in this case the phenotype is due to a complete absence of differentiated osteoclasts (Grigoriadis et al., 1994) . The expression of c-fos in differentiating osteoclasts and the rescue of the phenotype following transplantation of normal bone marrow suggest that this transcription factor is required for early osteoclast differentiation. Taken together, these mouse mutations not only emphasize the importance of osteoclastic activity in both the resorption of trabecular bone and the establishment of the definitive cortex, but also implicate several factors in osteoclast differentiation and activity.
Mechanical tension can also alter local bone architecture by influencing bone remodeling. The requirement for mechanical tension in the formation of bony tubercles at sites of tendon insertions is elegantly demonstrated in mice in which both the myf-5 and myoD genes are inactivated (Rudnicki et al., 1993) . These mice lack bony tubercles presumably as a result of impaired muscle development and therefore reduced mechanical tension at tendon insertion sites. While prostaglandins have been implicated, how tension is sensed by resident bone cells and how such signals contribute to the cellular and molecular control of bone remodeling are major unresolved issues in skeletal biology.
Bone remodeling itself is a poorly understood process. While much is known about the kinetics of bone turnover at the cellular level, little is understood about the local regulation of bone remodeling at the molecular level (reviewed by Canalis et al., 1991) . Presumably, specific factors regulate each step of a remodeling cycle, the coordination of remodeling with the local differentiation of osteoclasts and osteoblasts from their respective precursor cell populations, and the integration of bone remodeling with the endocrine control of bone turnover. Understanding these vario'us levels of control is important because deregulated bone remodeling lies at the basis of many metabolic bone diseases. For example, osteoporosis is characterized by reduced bone mass and is thought to result from an imbalance between bone formation and resorption. While the association of this disease with endocrinological imbalances such as reduced estrogen and increased corticosteroids has long been apparent, how these systemic factors influence the local regulation of bone remodeling is still not known. A recent example of this dichotomy comes from the association of reduced bone density with common alleles of the gene encoding the vitamin D receptor (Morrison et al., 1994) . Vitamin D stimulates osteoclast and osteoblast differentiation in vitro and regulates bone mineralization and homeostasis in vivo, but how changes in receptor expression lead to the cellular changes resulting in osteoporosis remains unclear. A potentially fruitful new approach to the problem is to establish appropriate transgenic mouse models to study the many paracrine growth and differentiation factors that, based upon cell culture studies, have been implicated in bone remodeling (see below). The initial success of this approach can be seen with the demonstration that transgenic mice overexpressing interleukin-4 develop os-teoporosis due to impaired osteoblastic function (Lewis et al., 1993) .
The Role of Collagens
Collagens represent the major proteins in bone and cartilage matrices and play an important role in determining the size, shape, and strength of these tissues (reviewed by van der Rest and Garrone, 1991) . Collagens form a family of at least 25 members, several of which are expressed at defined times and places during endochondral bone formation: collagen type II is the principal protein of cartilage, collagen type X is the major protein found in hypertrophic cartilage, and collagen type I is the most abundant protein in bone. All collagens contain globular domains at the amino and carboxyl termini and a triplehelical domain in between. Newly synthesized collagen monomers associate into trimeric microfibrils, which, once secreted, aggregate into larger structures. Based on their structure, the collagens can be subdivided into six distinct categories. Among these, the fibrillar collagens include types I, II, and Xl, the fibril-associated collagens include type IX, and the network collagens include type X collagen. The recent characterization of collagen mutations in mice and humans has provided insights into the function of different collagens in cartilage and bone (reviewed by Tilstra and Byers, 1994) .
The best-characterized fibrillar collagen is the type I collagen, which consists of two (~1(I) and one ~2(I) polypeptide chains. Mutations in the corresponding procollagen genes cause osteogenesis imperfecta, a heritable disorder resulting in decreased bone mass and bone fragility (reviewed by Byers and Steiner, 1992; Willing et al., 1993) . In addition, a wide range of clinical defects ranging from isolated osteoporosis to recurrent fractures and death in utero are also associated with collagen type I mutations. Several of the more than 100 molecular defects in procollagen type I genes characterized in humans have been reconstituted in transgenic mice with resulting bone defects. Analysis of human and mouse mutations have shown that null alleles give rise to mild phenotypes. Such mutations may result in altered mRNA levels or instability of the protein, perhaps through its inability to polymerize with the wild-type monomers. More severe phenotypes result from dominant negative mutations that result in an aberrant protein still capable of multimerizing with wild-type collagen type I fibrils. The severity of the phenotype depends on the nature and location of the mutation and on its effects on protein structure. In general, the impact of point mutations on the phenotype decreases as the mutation shifts toward the amino-terminal portion of the molecule. The relationship between genotype and phenotype has been reviewed elsewhere (Kuivaniemi et al., 1991) .
Mutations in collagen type II, a homotrimer of (~1(11), have been correlated with a variety of chondrodysplasias (reviewed by Vikkula et al., 1994) . This heterogeneous group of cartilage disorders may result in dwarfism, joint deformities, and other skeletal anomalies. As with collagen type I mutations, many different molecular defects have been reported, with dominant negative mutations resulting in the most severe defects in cartilage development and structure. The available transgenic mouse models with defects in collagen type II s/mould help clarify how such cartilage mutations affect subsequent endochondral bone formation. Recently, a patient with impaired chondrogenesis and with a documented dominant negative mutation in the (~1(11) gene was found to express collagen type I in chondrocytes, suggesting a possible compensatory mechanism for aberrant collagen type II expression (Freisinger et al., 1994) .
In this issue of Ceil, Li et al. (1995) and Vikkula et al. (1995) provide the first insights into the role of another fibrillar collagen, collagen type XI, in bone and cartilage formation. This minor component of cartilage collagen is thought to play a role in the regulation of collagen fibril diameter and the association of proteoglycans with the collagen fibrillar network. Li et al. (1995) report that a mutation in collagen type Xl lies at the basis of chondrodysplasia in cho/cho mice. In these mice, the absence of al(Xl) collagen expression results in severe abnormalities in cartilage of the limbs, ribs, mandible, and trachea and death at birth. At the epiphyses, the columnar arrangement of chondrocytes is disordered and chondrocytic maturation is delayed. In addition, the bones are wider but only about half the normal overall length. The collagen fibrils are abnormally thick and the proteoglycans are readily extractable, which is consistent with the purported function of collagen type XI. Vikkula et al. (1995) correlate a dominant negative mutation in the human COL11A2 gene encoding the ~2(Xl) chain with a form of Stickler syndrome, which is characterized by mild spondyloepiphyseal dysplasia, osteoarthritis, and sensorineural hearing loss. They also mapped a more severe autosomal recessive human osteochondrodysplasia to the COL 11A2 gene, and they speculate that this disease arises from a mutation resulting in a null allele. If this indeed proves to be the case, then it will be interesting to determine why such a mutation is lethal in the cho/cho mouse but not in human; as Vikkula et al. suggest , alternate collagen family members may be able to compensate for the null mutations in humans.
Collagen type IX is a prototype of another subset of collagens, the fibril-associated collagens. This collagen localizes to the surface of collagen II fibrils and was thought to play a major role in development. However, transgenic overexpression of a dominant negative mutant of collagen IX (Nakata et al., 1993) and gene inactivation in mice (Fassler et al., 1994) result in surprisingly mild phenotypes, characterized by degenerative joint disease resembling hur:nan osteoarthritis and mild chondrodysplasia. Thus, collagen IX may not play a major role in osteogenesis and chondrogenesis or in other human osteochondrodysplasias.
Finally, collagen X, a prototype of short chain collagens, is exclusively expressed in hypertrophic chondrocytes, where it forms distinct hexagonal arrays. Although its specific role in hypertrophic cartilage is not known, it may serve as a substrate for mineralization or vascular invasion. Some insight into its function has been gained through analysis of transgenic mouse models and characterization of human mutations (reviewed by Jacenko et al., 1994) . Mice with a mutant type X collagen transgene exhibit compression of the hypertrophic growth plate cartilage and decreased bone formation in a pattern that re-sembles spondylometaphyseal dysplasia and metaphyseal chondrodysplasias in humans. Subsequent analysis has confirmed that such patients indeed bear collagen X mutations, which are all localized to the carboxy-terminal, non-triple helical domain of the protein. The lack of detectable abnormalities in mice with an inactivated type X gene suggests that other collagens may compensate for its absence and emphasize again that null alleles of collagens result in a less severe phenotype than overexpression of a dominant negative mutant.
Mesenchymal Differentiation
The study of bone and cartilage cell differentiation in vitro provides an important counterpoint to the study of these cell populations in vivo. For example, experiments on cells derived from osteopetrotic mouse mutants will continue to add to the in vitro characterization of osteoclast differentiation. In vitro approaches have also made valuable contributions to our understanding of the differentiation of chondrecytes and osteoblasts. By analogy with other cell types, chondrocyte and osteoblast differentiation involves at least two distinct processes. First, precursor cells commit to the cartilage or bone lineages. Since these two lineages probably arise from the same population of undifferentiated mesenchymal cells, these studies have mainly concentrated on embryonic primary cultures and pluripotential mesenchymal cell lines. Second, consecutive maturation events lead to a fully differentiated phenotype, a process required in vivo for the constant replenishment of cartilage and bone cells from their respective committed precursor cell populations. Studies on the acquisition and modulation of the differentiated phenotype have mostly relied on cultures of committed precursor cells and tumor cell lines.
Members of the TGFI3 superfamily of secreted growth and differentiation factors have received considerable attention as potent regulators of mesenchymal differentiation in vivo and in vitro. Several BMPs are thought to regulate the early commitment of mesenchymal cells to the chondrogenic and osteogenic lineages, as suggested by their ability to induce ectopic cartilage and bone formation at nonskeletal sites such as muscle (Wozney et al., 1988; Wozney, 1992) . Accordingly, these factors can stimulate osteoblastic differentiation of both uncommitted and committed mesenchymal cells in vitro (Vukicevic et al., 1989; Yamaguchi et al., 1991; Wozney, 1992) and can induce cells other than osteoblasts to express osteoblastic markers (Katagiri et al., 1994) . TGFI3 itself may regulate the further differentiation of committed precursor cells, as suggested by its ability to induce cartilage and bone formation when administered under the periosteum (Joyce et al., 1990) , but not when injected into nonskeletal sites (Centrella et al., 1994) . TGFJ3 has also been shown to stimulate chondrocytic differentiation in vitro, but whether it modulates osteoblastic differentiation is unclear owing to differential responses in various cell systems (reviewed by Centrella et al., 1994) . The biological effects of different TGFJ3-related factors together with their expression patterns during cartilage and bone development suggest that distinct TGFI3s and BMPs act sequentially to drive successive stages of differentiation (Lyons et al., 1989; Rosen et al., 1994) . Consistent with such a model, differentiating cells may alter their responsiveness to these factors by modulating receptor levels (Centrella et al., 1994) and the associated signal transduction mechanisms (Siddhanti and Quarles, 1994) .
In vitro work has also identified many other extracellular factors that can modulate mesenchymal differentiation, including steroid and peptide hormones, growth and differentiation factors, and collagens and other extracellular matrix proteins. A full understanding of the effects of these factors on mesenchymal differentiation, however, has been hampered by the limitations of in vitro cell culture. One difficulty has been the lack of specific phenotypic markers to follow successive differentiation events. Type II collagen secretion is considered a major early marker of chondrocyte differentiation, while the synthesis of alkaline phosphatase is an early marker of osteoblast differentiation. Mature osteoblasts also produce osteopontin, osteonectin, and osteocalcin, three extracellular matrix proteins deposited together with type I collagen into mineralized bone matrix (Rodan and Noda, 1991) . Unfortunately, only a few differentiation markers have been identified, and several of these, such as alkaline phosphatase, osteopontin, and osteonectin, are not specific for osteogenic differentiation, while others, such as osteocalcin, are rarely expressed in vitro. In addition, mesenchymal cell lines and primary cultures of differentiating chondrocytes and osteoblasts display a variable phenotype and are often a mixture of cell types at different stages of differentiation. Finally, cells are typically cultured on plastic without a substrate of extracellular matrix. Such conditions may not allow complete differentiation since interaction with extracellular matrix proteins and a three-dimensional structure may be required for full differentiation. Accordingly, the development of appropriate three-dimensional in vitro systems is an important area of investigation (Stein and Lian, 1993) .
In vitro culture systems have also proven valuable in elucidating the cell-type specificity of signal transduction and transcriptional regulation. In this respect, mesenchymal cell lines are useful for the evaluation of osteoblast-and chondrocyte-specific transcription factors. Those belonging to the bH LH family are of particular interest because of their role in the commitment and differentiation of many cell types. For example, factors of the muscle-specific MyoD family are required for the differentiation of skeletal myoblasts and can induce several cell types to express a skeletal muscle phenotype (Olson and Klein, 1994) . In the case of osteoblasts, no specific bHLH genes have as yet been identified, yet indirect evidence suggests their existence. First, the expression of Id, an antagonist of bHLH protein binding to the promoter, is down-regulated during osteoblast differentiation (Ogata and Noda, 1991; Kawaguchi et al., 1992) , and overexpression of Id inhibits osteoblastic differentiation (Murray et al., 1992) . Second, the promoter regions of several genes expressed in osteoblasts contain E boxes, which can act as DNA-binding domains for bHLH proteins (Siddhanti and Quarles, 1994) . Finally, induction of osteoblastic differentiation is associated with increased binding of nuclear extracts to E boxes (Kawaguchi et al., 1992) . Once specific transcription factors are identified, studies assessing the interaction between these transcriptional regulators and known secreted osteoinductive factors will be of great importance in understanding the pat-terning and regulation of mesenchymal differentiation in vivo.
In conclusion, recent studies of mice and humans with various skeletal abnormalities have pointed to many genes important in bone and cartilage development. In vivo and in vitro approaches have also led to an understanding of some of the molecular mechanisms that control the activity and differentiation of bone and cartilage cells. In the future, the convergence of these various approaches should provide greater insight into the morphogenesis of this complex organ system.
